Understanding the needs of patients who use both methamphetamines and opioids in hospitals
Official title: Characteristics and outcomes for hospitalized patients with methamphetamine and opioid co-use: Identifying opportunities for hospital-based addiction services tailored to co-use
Funded at University of Minnesota · NIH-11042176 · Data updated 2026-11-12
This study is looking at how people who use both methamphetamines and opioids are treated in the hospital, so we can find better ways to help them get the care they need.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project start | March 1, 2023 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $41,837 |
| NIH project number | 5F30DA057775-03 |
| Project ID | NIH-11042176 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are hospitalized individuals who are using both methamphetamines and opioids.
✕Less likely to help
Patients who are not using either methamphetamines or opioids may not benefit from this research.
What this research studies
This research investigates the characteristics and outcomes of patients who are hospitalized due to the co-use of methamphetamines and opioids. It aims to identify how existing hospital addiction services can be improved to better serve these patients, who often have different needs compared to those using opioids alone. By analyzing patient demographics and hospitalization details, the study seeks to develop tailored treatment approaches that enhance care and support for individuals facing these dual addictions. The findings could lead to more effective hospital-based addiction services that address the unique challenges of co-use.
Why it matters
Potential benefit: If successful, this research could lead to improved addiction treatment services in hospitals, ultimately reducing overdose deaths and enhancing recovery outcomes for patients with co-use disorders.
How similar studies have gone: While there has been significant research on opioid use alone, this approach to studying co-use of methamphetamines and opioids is relatively novel and has not been extensively tested.
Where this research is happening
-
University of Minnesota
Minneapolis, United States Active
Researchers
- Principal investigator: Shearer, Riley — University of Minnesota
- Study coordinator: Shearer, Riley
Related research
Other NIH-funded projects on the same topics.
-
Reducing Addiction Risk in High Schools Through Better Prevention Infrastructure
Aims to build a sustainable, school-based system to prevent opioid and other drug use among high school students, especially those at higher risk.
-
HEAL Data Platform to share addiction-related data across programs
A platform project to make HEAL data from many programs easier to find and use, helping researchers and clinicians access information about addiction in children and youth.
-
Cognitively-enhanced tDCS to reduce cocaine craving
A study to test whether real brain stimulation together with learning strategies can lessen craving in people with cocaine use disorder.
-
Yale center researching how tobacco products affect use and addiction in people
A Yale research center is studying how nicotine, flavor additives, and other ingredients in tobacco products influence people’s likelihood of starting and becoming addicted.
-
Atherosclerosis in cocaine addiction: imaging risk with PET/MR
This project uses PET/MR imaging to look for early artery disease in people with cocaine use disorder to help prevent strokes or other brain injuries.
-
Integrating long-acting PrEP into street medicine for people who use drugs
This project tests whether a long-acting HIV prevention shot (lenacapavir) can be feasibly and acceptably offered by street-based health teams to people who use drugs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.